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Abstract CIpQ (HslV) is a homolog of the ~subnnits of the 
20S proteasome. In E. coli, it is expressed from an operon that 
also encodes ClpY (HslU), an ATPase homologous to the 
protease chaperone, ClpX. CIpQ (subunit Mr 19 000) and CIpY 
(subunit Mr 49000) were purified separately as oligomeric 
proteins with molecular weights of ,.-220000 and ,~ 350000, 
respectively, estimated by gel filtration. Mixtures of CIpY and 
ClpQ displayed ATP-dependent proteolytic activity against 
casein, and a complex of the two proteins was isolated by gel 
Filtration in the presence of ATP. Image processing of negatively 
stained electron micrographs revealed strong six-fold rotational 
symmetry for both CIpY and ClpQ, suggesting that the subunits 
of both proteins are arranged in hexagonal rings. The molecular 
weight of ClpQ combined with its symmetry is consistent with a 
double hexameric ring, whereas the data on CIpY suggest only 
one such ring. The symmetry mismatch previously observed 
between bexameric CIpA and heptameric CIpP in the related 
CIpAP protease is apparently not reproduced in the symmetry- 
matched CIpYQ system. 
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1. Introduction 
Substrate selection by the Clp family of ATP-dependent 
proteases is determined by a set of specific ATP-dependent 
molecular chaperones that interact with and activate proteo- 
lytic components [1-3]. In E. coli, two ATP-dependent molec- 
ular chaperones, ClpA and CIpX, activate ClpP, an oligo- 
meric protein that by itself displays only limited peptidase 
activity against low molecular weight peptides [4]. With 
ClpA, ClpP can degrade specific LacZ fusion proteins in 
vivo [5,6], as well as an endogenous E. coli protein, MazE 
[7], whereas, with ClpX, ClpP can degrade ~, O protein [8,9], 
the P1 protein, Phd [10], and the E. coli sigma factor, RpoS 
[11], in vivo. Another ATPase of the Clp family, CIpY (HslU) 
appears to interact with and activate ClpQ (HslV) [8,12-15], a
peptidase with no obvious evolutionary relatedness to ClpP. 
Specific substrates for ClpYQ in vivo have not been identified, 
although mutations in clpY and clpQ affect the levels of c E, 
an acute heat shock sigma factor [12]. 
We have been using negative staining electron microscopy 
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and image analysis of purified Clp proteins in order to estab- 
lish a structural basis for understanding the regulation and 
mechanism of action of Clp proteases. Previous studies dem- 
onstrated that ClpA is a symmetrical ring of six subunits 
[16], while ClpP is composed of two apposed rings of seven 
subunits each [16,17]. In the ClpAP complex, a hexameric 
ClpA ring is axially aligned on each face of the heptameric 
CIpP rings [16]. The mismatch in rotational symmetry be- 
tween ClpA and CIpP dictates that individual subunits within 
CIpA rings make non-equivalent contacts with subunits of 
ClpP, and has been conjectured to be of functional signifi- 
cance, perhaps in facilitating rotational movement or proces- 
sivity [16]. 
ClpAP displays a profound architectural similarity to the 
26S proteasome, despite the lack of sequence similarity with 
proteasomal components. This similarity may imply a com- 
mon mechanism of action. To explore the generality of this 
architecture, we have begun to examine the ClpYQ system. 
The heat shock hslUV operon of E. coli was identified by 
Chuang and Blattner [13] and shown by sequencing to encode 
two proteins, HslV (also called ClpQ [12]) and HslU (also 
called ClpY [8,12]). Because the latter is clearly related to 
the Clp family of ATPases, the names ClpY and ClpQ will 
be used in this paper. ClpY (subunit Mr 50 kDa) has a Walk- 
er-type consensus sequence for ATP-binding proteins [18] and 
has extensive homology to ClpX [8,13]. ClpQ (subunit Mr 19 
kDa) has homology to the I]-subunits of the 20S proteasome 
from Archaea and eukaryotes, including the catalytic amino 
terminal threonine residue [13,19]. The homology suggested 
that it might have a similar double-heptameric structure. 
Here, we show that ClpQ forms six-membered rather than 
seven-membered rings and that CIpY also contains ix-mem- 
bered rings. 
2. Materials and methods 
2.1. Materials 
ATP, 5'-adenosine imidyldiphosphate (AMPPNP), and ATPyS 
were obtained from Sigma, IPTG from Bachem, and polyethylene 
imine from ICN. MonoQ, Q Sepharose, and Superose 6 were pur- 
chased from Pharmacia. The TSK250 gel filtration was obtained from 
BioRad. All other chemicals were reagent grade. 
2.2. Cloning of clpQ and clp Y 
Double stranded DNA encoding either ClpQ or ClpY was prepared 
by amplification of E. coli chromosomal DNA using appropriate oli- 
gonucleotides derived from the published sequence of hslUV [13]. 
Amplified DNA was cloned into pVEX11, a derivative of a pET T7 
expression vector [20], using the NdeI and BamHI restriction sites. 
The sequences of clpQ and clpY, the fusion joints, and surrounding 
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DNA were confirmed by automated sequencing using an Applied 
Biosystems 373 DNA sequencer. 
2.3. Protein purification 
E. coli BL21/DE3 clpP: :Akan was transformed with pVEX11-clpQ 
and E. coli BL21/DE3 clpX: :Akan was transformed with pVEXll- 
clpY. Cells were grown in Luria broth to an Ar00 of 0.5, and produc- 
tion of T7 polymerase was induced by addition of 1 mM IPTG. After 
2 h, cells were harvested by centrifugation a d frozen at -70°C until 
used. To prepare crude extracts, frozen cells were thawed, suspended 
in 4 ml of 50 mM Tris, pH 7.5, 1 mM EDTA, 1 mM DTT, and 10%o 
(v/v) glycerol (buffer B) per g of cells, and broken by one pass through 
a French pressure cell at 20 000 psi. The extract was centrifuged at 
30000Xg for 45 min. A final concentration f 0.1% (w/v) polyeth- 
ylene imine was added to the supernatant, and precipitated material 
was removed by centrifugation at 30 000 x g for 30 min. 
For CIpQ, the supernatant solution was loaded onto a 2.6 × 20 cm 
column of Q Sepharose and proteins were eluted with a linear gradi- 
ent of KCI in the same buffer. Fractions with CIpQ were identified by 
SDS-PAGE analysis and pooled. CIpQ was precipitated by the addi- 
tion of cold acetone to 50% (v/v), collected by centrifugation, dis- 
solved in buffer B, loaded onto a Mono Q HR16/10 column, and 
eluted with a linear gradient of KCI. ClpQ was precipitated from 
the pooled fractions with 50% (v/v) acetone, dissolved in 3 ml buffer 
B plus 0.2 M KC1, and run through a 2.3 x 60 cm TSK250 gel filtra- 
tion column. Fractions containing ClpQ at ~ 95% purity were pooled 
and stored at -70°C. 
For ClpY, the polyethylene imine supernatant was loaded onto a 
MonoQ HR16/10 column and eluted with KCI. ClpY was precipitated 
from the pooled fractions with 60% saturated ammonium sulfate, 
dissolved in buffer B plus 0.2 M KC1, and run over a TSK250 gel 
filtration column. CIpY in the major fractions was ~ 90% pure. Small 
aliquots (< 1 mg) of CIpY were further purified as needed by gel 
filtration on a Superose 6 HR10/30 column. 
2.4. Protein and enzymatic assays 
Protein concentrations were estimated from the A2s0 of solutions 
and absorbance oefficients predicted from the amino acid sequences. 
Casein degradation assays were carried out as described previously [4]. 
2.5. Electron microscopy and image averaging 
Specimens were prepared by placing 4 [tl aliquots (20-50 txg/ml) 
protein in 50 mM Tris, pH 7.5, 0.2 M KCI, 1 mM EDTA, 1 mM 
DTT, 25 mM MgC12, 2 mM ATP, and 10% (v/v) glycerol on glow 
discharged carbon coated collodion covered grids. After 30 s excess 
buffer was blotted off. Aqueous 1% uranyl acetate was applied in 5-10 
drops, excess tain was blotted off, and the grids were allowed to dry. 
Micrographs were recorded at × 50 000 magnification i a Zeiss 902 
operating at 80 kV. 
Micrographs were digitized with a Perkin-Elmer 1010G flatbed mi- 
crodensitometer at 0.5 nm per pixel. General image processing and 
display operations were carried out using the PIC program [21] im- 
plemented on an Alpha workstation (Digital Equipment Corp., May- 
nard, MA). Particles were interactively extracted from digitized fields 
displayed on the workstation monitor, translationally aligned, ana- 
lyzed for rotational symmetry, and subjected to correlation averaging 
as described [22]. 
3. Results 
ClpQ and ClpY were overexpressed independently and pur- 
ified. Based on visual examination of Coomassie blue stained 
gels, ClpQ was judged to be > 95% pure and ClpY was 
> 90% pure after the final steps. The sequences of the amino 
terminal 20 amino acids of purified ClpQ (beginning at Thr-2) 
and the first 17 amino acids of ClpY matched those predicted 
from the DNA sequences. 
Table 1 shows that ClpQ was capable of degrading 
[3H]methyl-casein to acid-soluble peptides in the presence of 
CIpY and ATP. ClpQ alone had a slight ability to degrade 
casein, and degradation activity was activated > 10-fold in 
the presence of excess ClpY. ATP-activated peptide degrada- 
tion by ClpQ in the presence of ClpY was reported by the 
Chung and Goldberg laboratories [14,15]. 
Molecular weights of the purified proteins in the presence of 
ATP were estimated by gel filtration on Superose 6 (Fig. 1A). 
Apparent molecular weights were 2.2+0.2X105 for ClpQ 
(about 12 times the subunit molecular weight) and 
3.5 + 0.4X l0 n for ClpY (about 7 times the subunit molecular 
weight). A similar molecular weight for ClpQ was recently 
reported by another laboratory, but their estimate for ClpY 
in the presence of ATP (-,~ 500 000) was significantly higher 
than ours [14,15]. 
When ClpQ was examined by negative staining electron 
microscopy, a preponderance of uniformly sized particles 
(diameter 10-11 nm) was observed. A number of molecules 
had a seemingly hexagonal outline. Micrographs of well stained 
fields (e.g. Fig. 2, left) were digitized and analyzed using an 
algorithm that detects rotational symmetries [22]. In each of 
two independent data sets, an unequivocal six-fold symmetry 
was detected, most strongly at a radius of ~ 5 nm from the 
center, around the outer rim of the particles (Table 2). No 
other orders of symmetry were found to be statistically sig- 
nificant. The molecular images were then enhanced using cor- 
relation averaging, which consistently depicted a regular six- 
fold symmetric particle, with a heavy accumulation of stain at 
the center (e.g. Fig. 2, left, inset). In the averaged image, six 
bright mass densities mark the vertices of a hexagonal parti- 
cle, the edges of which have an inwardly scalloped contour. 
ClpY in the presence of MgATP was visualized by electron 
microscopy after negative staining, revealing fields of rounded 
molecules of relatively uniform size (Fig. 2, right). Rotational 
symmetry analysis detected only six-fold symmetry (Table 2), 
which again was statistically significant only on the outer 
edges of the particles. Correlation averaging of three inde- 
pendent data sets consistently produced images of ClpY as 
a regular hexagonal particle with a maximum dimension of 
,~ 13 nm between opposite vertices (Fig. 2, right, inset). Com- 
pared with ClpQ, ClpY is somewhat larger, has non-scalloped 
edges, and has a less pronounced accumulation of stain in the 
center. 
Because in the ClpAP complex association between ClpA 
and ClpP is stabilized by ATP, we anticipated that the affinity 
of ClpQ and ClpY for each other would be enhanced by an 
appropriate nucleotide. Fig. 1A shows that when a mixture of 
ClpY and ClpQ is run over a gel filtration column in the 
presence of MgATP, a species larger than both ClpY and 
ClpQ appeared. SDS-PAGE analysis of the column fractions 
showed that both ClpQ and ClpY were present in the higher 
molecular weight species (Fig. 1B). Thus, in the presence of 
nucleotide ClpY and ClpQ interact o form a complex isolat- 
able by gel filtration, although evidence of some dissociation 
is apparent in the trailing shoulders. The Mr of the ClpYQ 
Table 1 
ATP-dependent protein degradation by ClpYQ 
Addition --ATP +ATP 
(mg casein/h/mg) 
ClpY < 0.1 < 0.1 
CIpQ 0.2 0.2 
ClpY+CIpQ 0.2 6.5 
Casein degradation was assayed using 0.2 ~tg ClpQ and 2 Ixg ClpY. 
Activity is expressed per mg of the limiting component, CIpQ. 
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Fig. 1. Gel filtration of ClpQ, ClpY and the CIpYQ complex. A: A Superose 6 column was equilibrated with 50 mM Tris, pH 7.5, 0.2 M 
KC1, 1 mM EDTA, 1 mM DTT, 25 mM MgCI2, 2 mM ATP, and 10% (v/v) glycerol. Protein samples in 200 ~1 of the above buffer were 
loaded and the column was run at 0.3 ml/min. (zx) 300 ~tg CIpY; (©) 100 ktg ClpQ; (m) a mixture of 300 p.g CIpY and 100 p.g ClpQ. The ar- 
rows indicate the elution position of standard proteins: thyroglobulin (Mr 660 000), E. coli glutamine synthetase (Mr 600 000), E. coli glutamate 
dehydrogenase (Mr 285000), aldolase (Mr 160 000), ovalbumin (Mr 45 000), and myoglobin (Mr 17 000). A standard curve of log Mr versus elu- 
tion volume was used to estimate molecular weights of the proteins of interest with an accuracy of + 10%. B: SDS-PAGE analysis of proteins 
in the three gel filtration columns. Fractions of 0.6 ml were collected and 10 ~1 containing 1-2 p.g of protein were mixed with SDS sample buf- 
fer, heated at 100°C, and run on 12% polyacrylamide gels in SDS. The numbers refer to the elution volumes for the different columns of the 
fractions chosen for analysis. 
complex was > 600 000, consistent with a dodecamer of ClpQ 
interacting with at least one or possibly two hexamers of 
ClpY. Quantitat ion of the ClpY and ClpQ by scanning of 
the Coomassie stained SDS gels indicated that the complex 
had approximately equimolar amounts of  both proteins (data 
not shown). 
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Fig. 2. Electron micrographs and average images of ClpQ and CIpY. Negatively stained ClpQ and CIpY were prepared as described in Section 
2. Left: A typical field of wild-type ClpQ molecules; inset, averaged images of ClpQ viewed in en face projection. Right: Typical fields of wild- 
type ClpY molecules in the presence of ATP; inset, averaged images of ClpQ viewed in en face projection. Bar in insets is 50 rim. 
Table 2 
Image analysis of CIpY and ClpQ 
Sample Total particles SpectraP ratio Particles elected by Resolution b of averaged Dimensions c 
analyzed product OMO image (nm) 
A ClpY-1 d 96 6.0x 1028 77 2.8 13.5 
-2 200 1.3 x 101° 194 2.0 13.6 
-3 201 2.0x 1023 197 2.2 13.5 
B ClpQ-1 106 8.3 x 1014 103 3.2 11.0 
-2 139 4.5 x 107o 109 2.6 12.5 
~See Kocsis et al. [22]. The spectral ratio product is shown only for the radial zones in which these symmetries were detected most strongly (4.5-5.0 
nm for ClpQ and 5.5-6.5 nm for ClpY). 
bResolution was determined using the spectral-signal-to-noise cr t rion [32]. 
CThe maximum dimension of the particles taken as the distance between opposite vertices on the averaged hexagonal image. 
dNumbers efer to independent data sets. For ClpY, data sets 1 and 2 were from micrographs ofdifferent fields of the same grid and data set 3 was 
4. Discussion 
ClpQ has six-fold rotational symmetry, implying that it is 
composed of one or more rings of six subunits. The subunit 
Mr of 19 100 and approximate oligomeric Mr of 220000 are 
consistent with two such rings. Under our experimental con- 
ditions ClpY with bound ATP also forms an oligomer with 
six-fold rotational symmetry. Its Mr ("~ 350 000) together with 
subunit Mr of 50 000 indicates that this oligomer is a single 
ring of six subunits. We have on occasion and under different 
conditions observed a component of seven-fold symmetric 
ClpY oligomers (preliminary experiments: data not shown)Z; 
conditions that reproducibly form these apparent heptamers 
have not been defined. Micrographs of ClpY in the absence of 
nucleotide contained smaller less structurally defined particles, 
2Evidence for six- and seven-fold symmetry in CIpY and for six-fold 
symmetry in ClpQ has been obtained independently b A.L. Gold- 
berg, W. Baumeister, M. Rohrwild, H.C. Huang and A. Engel 
(Rohrwild, M. et al., submitted for publication). 
indicating less complete oligomerization (data not shown). 
Yoo et al. [15] observed lower molecular weight forms of 
ClpY upon gel filtration in the absence of ATP. However, 
under the conditions described here we reproducibly found 
ClpY with bound ATP to be predominantly hexameric. 
A recurrent structural feature of oligomeric proteins in- 
volved in protein unfolding and degradation appears to be 
an arrangement of subunits to form a donut or torus with a 
channel in the center [16,23-28]. The super-complexes com- 
prising the ATP-dependent proteases, e.g. the 26S proteasome 
[29] and ClpAP [16], are formed by axial stacking of two or 
more ring-shaped particles to form barrel-like structures with 
the two ATPase complexes related by relative rotation of 180 °
about a central proteolytic molecule possessing mirror sym- 
metry. The structure appears designed simultaneously to 
shield the proteolytic active sites in the center, provide sites 
for interaction with substrates atthe ends of the molecule, and 
allow substrates to be funneled through a central channel into 
the proteolytic active site cavity. From our data, the architec- 
ture of ClpYQ would be predicted to conform to this model. 
278 M. Kessel et al./FEBS Letters 398 (1996) 274-278 
Since seven-fold symmetry was first detected in the molecu- 
lar chaperone, GroEL [23], this symmetry has been detected in 
numerous other oligomeric haperones and proteases, includ- 
ing the accessory protein, GroES [30], the Archaea and the 
eukaryotic proteasomes, and E. coli ClpP [16]. However, other 
chaperones, uch as Hspl04 [31] and ClpA [16], both of which 
have two ATPase domains, have six-fold symmetry. Our find- 
ings that ClpY, with a single ATPase domain, and ClpQ, with 
only a proteolytic domain, also possess six-fold symmetry 
clearly indicate that there is no universal structural imperative 
for seven-fold symmetry in oligomeric protein-remodeling en- 
zymes. 
A symmetry mismatch between the ATPase and the proteo- 
lytic core, as in ClpAP, is an intriguing feature of that pro- 
tease. The presence of only six proteasome ATPase genes in 
yeast (D. Finley, personal communication) raises the possibil- 
ity that a similar mismatch may exist in the 26S proteasome. 
However, ClpY and ClpQ, with six subunits per ring, presum- 
ably form a symmetric omplex. Moreover, preliminary stud- 
ies of ClpX (provided by T. Baker, Massachusetts Institute 
of Technology) show that it has the same seven-fold symmetry 
as its proteolytic partner, ClpP (unpublished ata). Because 
functional complexes formed by interactions between rings of 
six (ClpYQ) or rings of seven (ClpXP) and between rings of 
six and seven (CIpAP) have been found, it follows that a 
symmetry mismatch is not an essential structural property 
of multi-component proteases. 
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